Sebastian Kosasih, Chrysavgi Mavrokefalou, Shahab Shahid, Naguib El-Muttardi, Ben Miranda
Our results support the clinical practice of treating closely excised SCCs as incomplete and treating closely excised BCCs as complete, perhaps with a follow-up period, in select cases such as when satisfying patient preference or minimising morbidity due to re-excision.
OBJECTIVE: The aim of nonmelanoma skin cancer (NMSC) excision is histologic clearance with margins of ≥1 mm, but evidence for close-margin management is scarce.
BACKGROUND: To compare complete, close, and incomplete excision recurrences.
METHODS: We performed a retrospective study of a subset of patients who underwent NMSC excision during 2020 to 2021. Lesions were grouped as complete (≥1 mm clearance), close (<1 mm), or incomplete (involved) and recurrence data were collected. Discrete data were analyzed using a χ2 test.
RESULTS: There were 421 lesions comprising 194 squamous cell carcinomas (SCCs; 49%) and 227 basal cell carcinomas (BCCs; 51%) included in the analysis. The mean follow-up was 29.3 months (standard deviation: 3.2), and the recurrence rate was 5%. There was a significantly greater risk of recurrence in closely (12%) vs completely (3%) excised SCCs (χ2=4.71; degrees of freedom [df]=1; P=0.03); however, no difference was demonstrated between close (12%) and incompletely (12%) excised SCCs (χ2<0.05; df=1; P=0.98). There was no statistical difference in recurrence rates between completely (1%) and closely (3%) excised BCCs (χ2=1.08; df=1; P=0.30), but a difference was found between closely (3%) and incompletely (16%) excised BCCs (χ2=6.33; df=1; P=0.01).
LIMITATIONS: Follow-up was <5 years, after which NMSCs may still recur.
CONCLUSION: Our results support the clinical practice of treating closely excised SCCs as incomplete and treating closely excised BCCs as complete, perhaps with a follow-up period, in select cases such as when satisfying patient preference or minimising morbidity due to re-excision.